Lifting the Veil in the European Medicines Agency
I wrote a number of blogs on the apparent change of policy on transparency by the European Medicines Agency when it published a new draft policy for targeted consultation last May – see here, here, and...
View ArticleLifting the veil in the European Medicines Agency Part 2
In my previous blog, I covered the apparent change of policy on transparency in the EMA and told how I requested access to various documents in the agency. You can see their letter of refusal again...
View ArticleOmbudsman Publishes Commission/EMA Correspondence on Transparency
As I mentioned previously the Ombudsman had, on her own initiative, looked into the apparent change of policy on transparency in the European Medicines Agency. She has now published on her website...
View ArticleA Bad Start for the New Commission
Some years ago, DG Sanco, the health directorate for public health, took over the lead role for medicines and medical devices from DG Enterprise the industry DG, which was responsible for promoting...
View ArticleThe Pharmaceutical Industry against Patients, Doctors and Pharmacists.
Joint letters with like-minded organisations are never easy to write, even among friends. Each organisation wants to add its own nuance.Different organisations may have different rules for sign-off on...
View ArticleMore Bad News – Mr Juncker replies to Concerns on Medicines
Mr Juncker has replied by letter to the concerns of the health sector on the transfer of medicines from DG Sanco to DG Enterprise/Internal Market. The letter says that one of the main priorities of the...
View ArticleClearing the Air on Transparency Decisions, and on Industry Demands to the...
At the Ombudsman’s recent conference two points were made that seem to contradict things I’ve said here. It is nice to have a blog to answer back. I said that the Commission had the final say on EMA’s...
View ArticlePersonal and Private? Correspondence between DG Enterprise and the...
Citing Regulation (EC) 1049/2001, I asked last month for access to the following documents: ‘All communications in any form, and notes or records in any form of communications between DG Enterprise and...
View ArticleIt’s Not All Bad News
In telling the Parliament on Wednesday that the units on medicines and pharmaceutical products will stay with DG Sanco Mr Juncker added “..I agree with you that medicines are not goods like any other”....
View ArticleAccess to Documents – Another Thrilling Episode
In a previous blog I said that I had requested access to documents on the dealings between DG Enterprise and pharmaceutical industry associations while the EMA was developing (and watering down) its...
View Article